secwatch.observer — SEC 8-K summary
======================================

Issuer:     UroGen Pharma Ltd. (URGN)
CIK:        0001668243
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001193125-25-030143
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

UroGen acquires ICVB-1042 assets from IconOVir for shares, milestone, and royalties
--------------------------------------------------------------------------------

- UroGen issued 374,843 ordinary shares (worth $4.0M) to IconOVir as upfront consideration.
- UroGen agreed to pay $15.0M cash milestone on cumulative global net sales of ICVB-1042 products.
- UroGen will pay low single-digit royalties on worldwide net sales of ICVB Products.
- Entities affiliated with Chair Arie Belldegrun hold promissory notes entitling them to ~28.3% of purchase price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668243/000119312525030143/0001193125-25-030143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668243/000119312525030143/d897858d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-030143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer